Stamford, CT -- (SBWIRE) -- 12/10/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), Cellceutix Corp (OTCMKTS:CTIX), Technip (ADR) (OTCMKTS:TKPPY), Nuvilex Inc (OTCMKTS:NVLX)
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) opened the session at $9.44, trading in a range of $9.44 - $9.57, and closed at $9.51. The stock showed a positive performance of +1.28% in the last trading session. The stock traded on a volume of 171,321 million shares and the average volume of the stock remained 75,772 shares. Telecom Corporation of New Zealand Limited provides telecommunications and IT services primarily in New Zealand and Australia. IT operates in five segments: Retail, Wholesale & International, Gen-I, AAPT, and Technology & Shared Services. The Retail segment provides fixed line, mobile, and Internet services to consumer, small and medium-sized enterprise (SME), corporate, enterprise, and wholesale customers.
For How Long NZTCY will Fight for Profitability? Read This Trend Analysis report
Cellceutix Corp (OTCMKTS:CTIX) traded 253,454 shares in the last business day while the average volume of the stock remained 163,641 shares. The stock showed a positive movement of +2.41% to end at $1.62. The 52 week range of the stock remained $1.18 - $2.47. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease. Its product candidates include Kevetrin, which is in Phase 1 trial for various solid tumor cancer types in patients with advanced-stage cancers; and various preclinical stage products comprising KM-133 for the treatment of psoriasis; KM 391 for the treatment of autism.
For How Long CTIX’s Gloss will Attract Investors? Find out via this report
Technip (ADR) (OTCMKTS:TKPPY) reported 78,228 shares were exchanged during the last trade, while the average volume is about 200,046 shares. The stock dropped -0.88% and finished the day at $24.79. The beta of the stock is recorded at 1.43. Technip provides project management, engineering, and construction services to the energy industry worldwide. It operates in two segments, Subsea and Offshore/Onshore. The Subsea segment offers integrated design, engineering, manufacturing, and installation services for infrastructures and subsea pipe systems used in oil and gas production and transportation
Why Should Investors Buy TKPPY After the Recent Fall? Just Go Here and Find Out
Nuvilex Inc (OTCMKTS:NVLX) the stock advanced +2.28% and finished the session at $0.130. Traded with volume of 1.51 million shares in the prior session and the average volume of the stock remained 1.51 million shares. Nuvilex, Inc, a biotechnology and life technology company, develops and markets products to improve the health, condition, and well-being. The company offers Cinnechol, a natural supplement, which helps in maintaining normal cholesterol levels and supports normal cardiovascular function; Cinnergen, a liquid whole food nutritional supplement that provides nutrients to help the body process glucose.
Why Should Investors Buy NVLX After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)